Market Research Report Title Publication Date Pages Price
Sickle Cell Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Soft Tissue Sarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Urinary Incontinence - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Sinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Short Bowel Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Vancomycin-Resistant Enterococcus Faecium Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Peripheral Neuropathic Pain - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Iron Deficiency Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
 Pruritus - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
 Varicella Zoster (HHV-3) Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 120 USD 2,250.00
 Insulin Resistance - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Otitis Media - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Waldenstrom Macroglobulinemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Peptic Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Infantile Spasm  - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Influenza A Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Impetigo - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Paroxysmal Nocturnal Hemoglobinuria - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Peanut Allergy - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Liposarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Liver Failure - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Partial Seizure - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Left Ventricular Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Lupus Nephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Moderate Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 120 USD 2,250.00
Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Gastroparesis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Infantile Spasm - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Gastritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Ischemic Stroke - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Klebsiella Pneumoniae Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Dyspepsia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Idiopathic Short Stature - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Blepharitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Malignant Mesothelioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Bacterial Vaginosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Metastatic Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Metastatic Hepatocellular Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Metastatic Renal Cell Carcinoma (mRCC) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Medullary Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Anterior Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Male Hypogonadism - Global API Manufacturers, Marketed and Phase III Drugs Landscape 120 USD 2,250.00
Nasopharyngeal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Displaying 151 - 200 of 2417
Subscribe to Drug Pipeline